Cargando…
Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677482/ https://www.ncbi.nlm.nih.gov/pubmed/32591355 http://dx.doi.org/10.1136/annrheumdis-2020-217255 |
_version_ | 1783611983694659584 |
---|---|
author | Costello, Ruth E Humphreys, Jenny H Winthrop, Kevin L Dixon, William G |
author_facet | Costello, Ruth E Humphreys, Jenny H Winthrop, Kevin L Dixon, William G |
author_sort | Costello, Ruth E |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7677482 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-76774822020-11-30 Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis Costello, Ruth E Humphreys, Jenny H Winthrop, Kevin L Dixon, William G Ann Rheum Dis Letter BMJ Publishing Group 2020-12 2020-06-26 /pmc/articles/PMC7677482/ /pubmed/32591355 http://dx.doi.org/10.1136/annrheumdis-2020-217255 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Letter Costello, Ruth E Humphreys, Jenny H Winthrop, Kevin L Dixon, William G Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis |
title | Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis |
title_full | Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis |
title_fullStr | Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis |
title_full_unstemmed | Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis |
title_short | Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis |
title_sort | pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677482/ https://www.ncbi.nlm.nih.gov/pubmed/32591355 http://dx.doi.org/10.1136/annrheumdis-2020-217255 |
work_keys_str_mv | AT costelloruthe pneumoniavaccinationtiminginrelationtostartingconventionalsyntheticdiseasemodifyingantirheumaticdrugsinpatientswithrheumatoidarthritis AT humphreysjennyh pneumoniavaccinationtiminginrelationtostartingconventionalsyntheticdiseasemodifyingantirheumaticdrugsinpatientswithrheumatoidarthritis AT winthropkevinl pneumoniavaccinationtiminginrelationtostartingconventionalsyntheticdiseasemodifyingantirheumaticdrugsinpatientswithrheumatoidarthritis AT dixonwilliamg pneumoniavaccinationtiminginrelationtostartingconventionalsyntheticdiseasemodifyingantirheumaticdrugsinpatientswithrheumatoidarthritis |